Clinical Trial – Oral Immunotherapy in Severe Milk, Peanut and Egg Allergy in Adults – Allergy

The aim is to analyse the results of per oral immunotherapy treatment in severe milk, peanut or egg allergy in adults. This is the second part of the oral immunotherapy study in adults at Skin and Allergy Hospital. The diagnosis of food allergy is verified with positive history, skin prick tests, egg and milk allergen specific IgE (immunoglobulin E) antibodies. In addition, food allergy is verified with an open label (milk allergy) or blind (peanut and egg allergy) allergen specific challenge test. OIT (oral immunotherapy) is performed according to a detailed plan. Lung function parameters are followed before OIT and and a year after OIT.

Study Type  : Interventional  (Clinical Trial)
Estimated Enrollment  : 100 participants
Allocation: Non-Randomized
Intervention Model: Parallel Assignment
Intervention Model Description: Prospective open label study on oral immunotherapy with either milk, or peanut or egg white food products.
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: The Effect of Per Oral Immunotherapy Treatment in Severe IgE Mediated Milk, Peanut and Egg Allergy in Adults
Actual Study Start Date  : August 3, 2017
Estimated Primary Completion Date  : December 31, 2022
Estimated Study Completion Date  : December 31, 2022
Contacts
Contact: Paula Kauppi, MD, PhD +358504286802 paula.kauppi@hus.fi

 

Locations
Finland
Helsinki University Central Hospital Recruiting
Helsinki, Finland, 00029
Contact: Paula M Kauppi       paula.kauppi@hus.fi
Contact: Mika J Mäkelä       mika.makela@hus.fi

 

ClinicalTrials.gov Identifier: NCT03361072
* The Content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.